Important note: Odyssey Acquisition S.A. will be renamed BenevolentAI following completion of the Business Combination and approval of the Prospectus, both scheduled for 22 April 2022. BenevolentAI’s securities will be admitted to Euronext Amsterdam on 25 April 2022. The final number of BenevolentAI securities to be admitted on Euronext Amsterdam will be provided on 22 April 2022, following approval of the Prospectus. Upon admisison of BenevolentAI’s securities on 25 April, this IPO Showcase page will be amended to reflect BenevolentAI’s information.

Identification

Listing sponsor / Euronext Growth Advisor
ABN AMRO BANK N.V.
Ticker
BAI
Codice ISIN
LU2355630455
codice LEI
2221003P54KEDC3P4Z33
Mercato
Euronext
Borsa
Amsterdam
Comparto
Compartment A
ICB
20103010 Biotechnology
Indirizzo web
https://www.benevolent.com

Operation

Data IPO
Lun 25/04/2022
Tipologia IPO
SPAC – Business combination
Descrizione dell'operazione

The final number of securities to be admitted to Euronext Amsterdam will be provided upon publication of the approved prospectus on 22 April, 2022